Depression in Cognitive Impairment

Por Pellegrino, Laurel D., Peters, Matthew E., Lyketsos, Constantine G., Marano, Christopher M.
Publicado em 2013

Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis

Por Regenold, William T., Phatak, Pornima, Marano, Christopher M., Sassan, Amritpal, Conley, Robert R., Kling, Mitchel A.
Publicado em 2008

Structural Imaging in Late Life Depression: Association with Mood and Cognitive Responses to Antidepressant Treatment

Por Marano, Christopher M., Workman, Clifford I., Lyman, Christopher H., Munro, Cynthia A., Kraut, Michael A., Smith, Gwenn S.
Publicado em 2013

Longitudinal Studies of Cerebral Glucose Metabolism in Late-Life Depression and Normal Aging

Por Marano, Christopher M., Workman, Clifford I., Kramer, Elisse, Hermann, Carol R., Ma, Yilong, Dhawan, Vijay, Chaly, Thomas, Eidelberg, David, Smith, Gwenn S.
Publicado em 2012

Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker

Por Oh, Esther S., Marano, Christopher M., Leoutsakos, Jeannie-Marie, Lee, Rebecca W., Rissman, Robert A., Smith, Gwenn S., Craft, Suzanne, Lyketsos, Constantine G.
Publicado no Alzheimers Dement (Amst) (2015)

The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging

Por Marano, Christopher M., Workman, Clifford I., Lyman, Christopher H., Kramer, Elisse, Hermann, Carol R., Ma, Yilong, Dhawan, Vijay, Chaly, Thomas, Eidelberg, David, Smith, Gwenn S.
Publicado no Psychiatry Res (2014)

Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients

Por Regenold, William T, Hisley, K Calvin, Phatak, Pornima, Marano, Christopher M, Obuchowski, Abraham, Lefkowitz, David M, Sassan, Amritpal, Ohri, Sameer, Phillips, Tony L, Dosanjh, Narveen, Conley, Robert R, Gullapalli, Rao
Publicado em 2008

Molecular Imaging of Serotonin Degeneration in Mild Cognitive Impairment

Por Smith, Gwenn S., Barrett, Frederick S., Joo, Jin Hui, Nassery, Najlla, Savonenko, Alena, Sodums, Devin J., Marano, Christopher M., Munro, Cynthia A., Brandt, Jason, Kraut, Michael A., Zhou, Yun, Wong, Dean F., Workman, Clifford I.
Publicado no Neurobiol Dis (2017)

Association between serotonin denervation and resting‐state functional connectivity in mild cognitive impairment

Por Barrett, Frederick S., Workman, Clifford I., Sair, Haris I., Savonenko, Alena V., Kraut, Michael A., Sodums, Devin J., Joo, Jin J., Nassery, Najlla, Marano, Christopher M., Munro, Cynthia A., Brandt, Jason, Zhou, Yun, Wong, Dean F., Smith, Gwenn S.
Publicado no Hum Brain Mapp (2017)

Citalopram for agitation in Alzheimer’s disease (CitAD): design and methods

Por Drye, Lea T., Ismail, Zahinoor, Porsteinsson, Anton P., Rosenberg, Paul B., Weintraub, Daniel, Marano, Christopher, Pelton, Gregory, Frangakis, Constantine, Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Devanand, D.P., Yesavage, Jerome, Mintzer, Jacobo E., Schneider, Lon S., Pollock, Bruce G., Lyketsos, Constantine G.
Publicado em 2012

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

Por Drye, Lea T., Spragg, David, Devanand, D. P., Frangakis, Constantine, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Pollock, Bruce G., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado em 2014

Effect of Citalopram on Agitation in Alzheimer's Disease – The CitAD Randomized Controlled Trial

Por Porsteinsson, Anton P., Drye, Lea T., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado em 2014

Time to response to citalopram treatment for agitation in Alzheimer's disease

Por Weintraub, Daniel, Drye, Lea T., Porsteinsson, Anton P., Rosenberg, Paul B., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Yesavage, Jerome, Lyketsos, Constantine G.
Publicado no Am J Geriatr Psychiatry (2015)

Change in agitation in Alzheimer's disease in the placebo arm of a 9-week controlled trial

Por Rosenberg, Paul B., Drye, Lea T., Porsteinsson, Anton P., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Newell, Jeffery, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado no Int Psychogeriatr (2015)